Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye

Journal of Antibiotics

Volumn 64, Issue 4, 2011, Pages 321-325

  Silva, Filomena ^a   Lourenço, Olga ^a   Queiroz, João A ^a   Domingues, Fernanda C ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

bacterial DNA; ciprofloxacin; flow cytometry; Vybrant DyeCycle Ruby

Indexed keywords

BACTERIAL DNA; CIPROFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELL GROWTH; CONTROLLED STUDY; DNA DETERMINATION; DRUG ACTIVITY; ESCHERICHIA COLI; FAR RED LIGHT; FLOW CYTOMETRY; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENT DYES; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 79955560989     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.5     Document Type: Article

References (29)

1. Pankey, G. A. & Sabath, L. D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38, 864-870 (2004). (Pubitemid 38387236)
2. Drlica, K. & Zhao, X. Mutant selection window hypothesis updated. Clin. Infect. Dis. 44, 681-688 (2007).
3. Stratton, C. W. Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg. Infect. Dis. 9, 10-16 (2003). (Pubitemid 36110196)
4. Barbesti, S. et al. Two and three-color fluorescence flow cytometric analysis of immunoidentified viable bacteria. Cytometry 40, 214-218 (2000). (Pubitemid 30441524)
5. Telford, W. G., Bradford, J., Godfrey, W., Robey, R. W. & Bates, S. E. Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells 25, 1029-1036 (2007). (Pubitemid 46572601)
6. Mori,T.et al. A stable human progesterone receptor expressing HeLa reporter cell line as a tool in chemical evaluation at the different cell-cycle phases. Toxicol. Lett. 186, 123-129 (2009).
7. Mukherjee, C., Majumder, S. & Lohia, A. Inter-cellular variation in DNA content of Entamoeba histolytica originates from temporal and spatial uncoupling of cytokinesis from the nuclear cycle. PLoS Negl. Trop. Dis. 3, e409 (2009).
8. Zemans, R. L. et al. A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction. J. Immunol. Methods 340, 102-115 (2009).
9. Silva,F.et al. The use of DRAQ5 to monitor intracellular DNA in Escherichia coli by flow cytometry. J. Fluoresc. 20, 907-914 (2010).
10. Demain, A. L. & Sanchez, S. Microbial drug discovery: 80 years of progress. J. Antibiot. (Tokyo) 62, 5-16 (2009).
11. Drlica, K. Mechanism of fluoroquinolone action. Curr. Opin. Microbiol. 2, 504-508 (1999). (Pubitemid 29477177)
12. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-sixth edition: approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA (2003).
13. NCCLS. Methods for determining bactericidal activity of antimicrobial agents; approved guidelines, M26-A, vol. 19. National Committee for Clinical Laboratory Standards, Wayne, PA (1999).
14. Chen, C. Y., Nace, G. W. & Irwin, P. L. A 6 × 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J. Microbiol. Methods 55, 475-479 (2003). (Pubitemid 37177048)
15. NCCLS. Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA (1999).
16. Petersen, P. J., Jones, C. H. & Bradford, P. A. In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth. Diagn. Microbiol. Infect. Dis. 59, 347-349 (2007). (Pubitemid 350016698)
17. Paulo, L., Ferreira, S., Gallardo, E., Queiroz, J. A. & Domingues, F. Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J Microbiol Biotechnol 26, 1533-1538 (2010).
18. Mathew, G.. et al. ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate. Cell Cycle 8, 1053-1061 (2009).
19. Lesley, J. A. & Shapiro, L. SpoTregulates DnaA stability and initiation of DNA replication in carbon-starved Caulobacter crescentus. J. Bacteriol. 190, 6867-6880 (2008).
20. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. J. Antimicrob. Chemother. 39 (Suppl B), 23-27 (1997). (Pubitemid 27299975)
21. Mason, D. J., Power, E. G., Talsania, H., Phillips, I. & Gant, V. A. Antibacterial action of ciprofloxacin. Antimicrob. Agents Chemother. 39, 2752-2758 (1995).
22. Wickens, H. J., Pinney, R. J., Mason, D. J. & Gant, V. A. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure. Antimicrob. Agents Chemother. 44, 682-687 (2000). (Pubitemid 30117961)
23. Nebe-von-Caron, G., Stephens, P. J., Hewitt, C. J., Powell, J. R. & Badley, R. A. Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sorting. J. Microbiol. Methods 42, 97-114 (2000).
24. Tamayo, M., Santiso, R., Gosalvez, J., Bou, G. & Fernandez, J. L. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay. BMC Microbiol. 9, 69 (2009).
25. Hawkey, P. M. Mechanisms of quinolone action and microbial response. J. Antimicrob. Chemother. 51(Suppl 1), 29-35 (2003). (Pubitemid 36622102)
26. Drlica, K., Engle, E. C. & Manes, S. H. DNA gyrase on the bacterial chromosome: possibility of two levels of action. Proc. Natl Acad. Sci. USA 77, 6879-6883 (1980). (Pubitemid 11219049)
27. Fernandez, J L et al. DNA fragmentation in microorganisms assessed in situ. Appl. Environ. Microbiol. 74, 5925-5933 (2008).
28. Walberg, M., Gaustad, P. & Steen, H. B. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry. Cytometry 27, 169-178 (1997). (Pubitemid 27101547)
29. Johansson, L. & Liden, G. A study of long-term effects on plasmid-containing Escherichia coli in carbon-limited chemostat using 2D-fluorescence spectrofluorimetry. Biotechnol. Prog. 22, 1132-1139 (2006). (Pubitemid 44230702)